Urokinase Receptor Regulates Adhesion of Progenitor Cardiac Cells to Vitronectin
- 作者: Dergilev K.1, Tsokolaeva Z.1, Beloglazova I.1, Zubkova E.1, Ratner E.1, Molokotina Y.1, Parfenova E.1,2
-
隶属关系:
- Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
- Laboratory of Postgenomic Technologies in Medicine, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University
- 期: 卷 167, 编号 3 (2019)
- 页面: 315-319
- 栏目: General Pathology and Pathophysiology
- URL: https://journals.rcsi.science/0007-4888/article/view/241674
- DOI: https://doi.org/10.1007/s10517-019-04517-w
- ID: 241674
如何引用文章
详细
Vitronectin, extracellular matrix protein, plays an important role in embryonic development and in organ and tissue reparation. A unique characteristic of vitronectin is specific binding of various biological molecules, including urokinase receptor (uPAR), extracellular matrix components, adhesion receptors, growth factors, thus supporting the modulation of cell behavior. Vitronectin is in fact not found in intact myocardium, while after infarction its level increases significantly, which correlates with accumulation of uPAR+ progenitor cardiac cells in the focus. The cells isolated from the heart of wild type mice are characterized by higher adhesion to vitronectin than progenitor cardiac cells from the myocardium of uPAR knockout mice. In addition, inhibition of urokinase receptor with specific antibodies on the surface of the progenitor cardiac cells of wild type mice leads to attenuation of their adhesive activity and flattening on vitronectin matrix, which can be important for their distribution in the postinfarction myocardium and realization of the reparative functions.
作者简介
K. Dergilev
Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: doctorkote@gmail.com
俄罗斯联邦, Moscow
Z. Tsokolaeva
Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: doctorkote@gmail.com
俄罗斯联邦, Moscow
I. Beloglazova
Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: doctorkote@gmail.com
俄罗斯联邦, Moscow
E. Zubkova
Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: doctorkote@gmail.com
俄罗斯联邦, Moscow
E. Ratner
Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: doctorkote@gmail.com
俄罗斯联邦, Moscow
Yu. Molokotina
Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Email: doctorkote@gmail.com
俄罗斯联邦, Moscow
E. Parfenova
Laboratory of Angiogenesis, Institute of Experimental Cardiology, National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation; Laboratory of Postgenomic Technologies in Medicine, Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University
Email: doctorkote@gmail.com
俄罗斯联邦, Moscow; Moscow
![](/img/style/loading.gif)